| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.77M | 30.41M | 21.85M | 8.82M | 10.82M | 9.03M |
| Gross Profit | 5.36M | 17.83M | 8.07M | 3.35M | 5.19M | 4.02M |
| EBITDA | -14.35M | -4.46M | -4.16M | -6.55M | 163.53K | 399.69K |
| Net Income | -10.81M | -1.48M | -4.19M | -6.68M | -338.16K | 150.96K |
Balance Sheet | ||||||
| Total Assets | 13.34M | 13.97M | 19.62M | 12.14M | 9.12M | 10.36M |
| Cash, Cash Equivalents and Short-Term Investments | 4.35M | 6.62M | 1.95M | 7.18M | 3.14M | 3.06M |
| Total Debt | 946.72K | 3.78M | 4.89M | 4.55M | 6.19M | 8.49M |
| Total Liabilities | 9.51M | 10.50M | 11.96M | 7.33M | 9.68M | 11.42M |
| Stockholders Equity | 5.19M | 4.65M | 5.17M | 4.81M | -558.95K | -1.41M |
Cash Flow | ||||||
| Free Cash Flow | -4.26M | -4.78M | -4.86M | -4.87M | 730.15K | 718.58K |
| Operating Cash Flow | -4.26M | -4.77M | -4.33M | -4.81M | 766.30K | 745.75K |
| Investing Cash Flow | 4.81M | 6.35M | -1.78M | -12.20K | -179.03K | -401.15K |
| Financing Cash Flow | 1.21M | -318.65K | 136.19K | 8.92M | -257.35K | 2.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | $6.92M | -0.36 | -80.59% | ― | -27.47% | 83.06% | |
43 Neutral | $6.22M | -0.46 | -5.71% | 41.26% | -51.26% | -319.52% | |
40 Underperform | $7.61M | -0.04 | -269.14% | ― | -73.83% | 98.11% |
On November 10, 2025, HeartCore Enterprises, Inc. announced it received an additional 180-day extension from the Nasdaq Listing Qualifications Department to meet the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The extension, which lasts until May 1, 2026, has no immediate effect on the company’s stock listing status, but failure to comply could lead to delisting. HeartCore is considering actions such as a reverse stock split to regain compliance, though no decisions have been made yet.
The most recent analyst rating on (HTCR) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on HeartCore Enterprises, Inc. stock, see the HTCR Stock Forecast page.